Literature DB >> 27914066

Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.

Wenkang Huang1, Ruth Nussinov2,3, Jian Zhang4.   

Abstract

Allostery is an intrinsic phenomenon of biological macromolecules involving regulation and/or signal transduction induced by a ligand binding to an allosteric site distinct from a molecule's active site. Allosteric drugs are currently receiving increased attention in drug discovery because drugs that target allosteric sites can provide important advantages over the corresponding orthosteric drugs including specific subtype selectivity within receptor families. Consequently, targeting allosteric sites, instead of orthosteric sites, can reduce drug-related side effects and toxicity. On the down side, allosteric drug discovery can be more challenging than traditional orthosteric drug discovery due to difficulties associated with determining the locations of allosteric sites and designing drugs based on these sites and the need for the allosteric effects to propagate through the structure, reach the ligand binding site and elicit a conformational change. In this study, we present computational tools ranging from the identification of potential allosteric sites to the design of "allosteric-like" modulator libraries. These tools may be particularly useful for allosteric drug discovery.

Entities:  

Keywords:  Allosteric drug design; Allosteric drug discovery; Allosteric modulator; Allosteric site; Allostery

Mesh:

Substances:

Year:  2017        PMID: 27914066      PMCID: PMC7920515          DOI: 10.1007/978-1-4939-6637-0_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  32 in total

1.  The different ways through which specificity works in orthosteric and allosteric drugs.

Authors:  Ruth Nussinov; Chung-Jung Tsai
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Allosteric regulation and catalysis emerge via a common route.

Authors:  Nina M Goodey; Stephen J Benkovic
Journal:  Nat Chem Biol       Date:  2008-08       Impact factor: 15.040

3.  Toward an understanding of the sequence and structural basis of allosteric proteins.

Authors:  Xiaobai Li; Yingyi Chen; Shaoyong Lu; Zhimin Huang; Xinyi Liu; Qi Wang; Ting Shi; Jian Zhang
Journal:  J Mol Graph Model       Date:  2013-01-05       Impact factor: 2.518

Review 4.  Harnessing allostery: a novel approach to drug discovery.

Authors:  Shaoyong Lu; Shuai Li; Jian Zhang
Journal:  Med Res Rev       Date:  2014-05-14       Impact factor: 12.944

5.  Ensemble properties of network rigidity reveal allosteric mechanisms.

Authors:  Donald J Jacobs; Dennis R Livesay; James M Mottonen; Oleg K Vorov; Andrei Y Istomin; Deeptak Verma
Journal:  Methods Mol Biol       Date:  2012

Review 6.  The role of dynamic conformational ensembles in biomolecular recognition.

Authors:  David D Boehr; Ruth Nussinov; Peter E Wright
Journal:  Nat Chem Biol       Date:  2009-11       Impact factor: 15.040

7.  ASD: a comprehensive database of allosteric proteins and modulators.

Authors:  Zhimin Huang; Liang Zhu; Yan Cao; Geng Wu; Xinyi Liu; Yingyi Chen; Qi Wang; Ting Shi; Yaxue Zhao; Yuefei Wang; Weihua Li; Yixue Li; Haifeng Chen; Guoqiang Chen; Jian Zhang
Journal:  Nucleic Acids Res       Date:  2010-11-04       Impact factor: 16.971

Review 8.  Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology.

Authors:  Bruno O Villoutreix; Melaine A Kuenemann; Jean-Luc Poyet; Heriberto Bruzzoni-Giovanelli; Céline Labbé; David Lagorce; Olivier Sperandio; Maria A Miteva
Journal:  Mol Inform       Date:  2014-06-02       Impact factor: 3.353

9.  Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.

Authors:  Jianming Zhang; Francisco J Adrián; Wolfgang Jahnke; Sandra W Cowan-Jacob; Allen G Li; Roxana E Iacob; Taebo Sim; John Powers; Christine Dierks; Fangxian Sun; Gui-Rong Guo; Qiang Ding; Barun Okram; Yongmun Choi; Amy Wojciechowski; Xianming Deng; Guoxun Liu; Gabriele Fendrich; André Strauss; Navratna Vajpai; Stephan Grzesiek; Tove Tuntland; Yi Liu; Badry Bursulaya; Mohammad Azam; Paul W Manley; John R Engen; George Q Daley; Markus Warmuth; Nathanael S Gray
Journal:  Nature       Date:  2010-01-13       Impact factor: 49.962

10.  ASD v2.0: updated content and novel features focusing on allosteric regulation.

Authors:  Zhimin Huang; Linkai Mou; Qiancheng Shen; Shaoyong Lu; Chuangang Li; Xinyi Liu; Guanqiao Wang; Shuai Li; Lv Geng; Yaqin Liu; Jiawei Wu; Guoqiang Chen; Jian Zhang
Journal:  Nucleic Acids Res       Date:  2013-11-28       Impact factor: 16.971

View more
  3 in total

1.  Spectral analysis of molecular dynamics simulations on PDZ: MD sectors.

Authors:  Bharat Lakhani; Kelly M Thayer; Emily Black; David L Beveridge
Journal:  J Biomol Struct Dyn       Date:  2019-07-01

Review 2.  PI3K inhibitors: review and new strategies.

Authors:  Mingzhen Zhang; Hyunbum Jang; Ruth Nussinov
Journal:  Chem Sci       Date:  2020-05-19       Impact factor: 9.825

Review 3.  Mechanism of activation and the rewired network: New drug design concepts.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Chung-Jung Tsai; Bengi Ruken Yavuz; Nurcan Tuncbag; Hyunbum Jang
Journal:  Med Res Rev       Date:  2021-10-25       Impact factor: 12.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.